Author Insights: Some Clinical Trials Intended for Drug Marketing, Not Advancing Science

A report appearing today in the Archives of Internal Medicine uses court documents related to a product liability lawsuit to detail the running of a “seeding trial.” Such trials, which occur after a drug is approved, are primarily conducted to promote drugs and increase prescribing among physicians who partake in these studies rather than to advance scientific knowledge.

Back to news